Martingale Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,809
| Closed | -$513K | – | 817 |
|
|
2024
Q3 | $513K | Buy |
12,809
+4
| +0% | +$160 | 0.01% | 619 |
|
|
2024
Q2 | $610K | Sell |
12,805
-510
| -4% | -$24.3K | 0.01% | 561 |
|
|
2024
Q1 | $577K | Buy |
13,315
+3
| +0% | +$130 | 0.01% | 593 |
|
|
2023
Q4 | $673K | Sell |
13,312
-722
| -5% | -$36.5K | 0.01% | 536 |
|
|
2023
Q3 | $637K | Hold |
14,034
| – | – | 0.01% | 557 |
|
|
2023
Q2 | $576K | Buy |
14,034
+91
| +0.7% | +$3.73K | 0.01% | 586 |
|
|
2023
Q1 | $498K | Buy |
13,943
+3,582
| +35% | +$128K | 0.01% | 618 |
|
|
2022
Q4 | $391K | Buy |
10,361
+648
| +7% | +$24.5K | 0.01% | 671 |
|
|
2022
Q3 | $431K | Buy |
9,713
+2,308
| +31% | +$102K | 0.01% | 645 |
|
|
2022
Q2 | $275K | Hold |
7,405
| – | – | 0.01% | 749 |
|
|
2022
Q1 | $275K | Buy |
+7,405
| New | +$275K | ﹤0.01% | 743 |
|